Gut Microbiota-Derived Inflammation-Related Serum Metabolites as Potential Biomarkers for Major Depressive Disorder

References

• Frankish H, Boyce N, Horton R. Mental health for all: a global goal. Lancet. 2018;392(10157):1493–1494. doi:10.1016/S0140-6736(18)32271-2
   PubMed Web of Science ®Google Scholar
• Liao D, Chen Y, Guo Y, et al. Salvianolic acid b improves chronic mild stress-induced depressive behaviors in rats: involvement of AMPK/SIRT1 signaling pathway. J Inflamm Res. 2020;13:195–206. doi:10.2147/JIR.S249363
   PubMed Web of Science ®Google Scholar
• Wang HQ, Wang ZZ, Chen NH. The receptor hypothesis and the pathogenesis of depression: genetic bases and biological correlates. Pharmacol Res. 2021;167:105542. doi:10.1016/j.phrs.2021.105542
   PubMed Web of Science ®Google Scholar
• Beirão D, Monte H, Amaral M, Longras A, Matos C, Villas-Boas F. Depression in adolescence: a review. Middle East Curr Psychiatry. 2020;27:50. doi:10.1186/s43045-020-00050-z
   Google Scholar
• Yano JM, Yu K, Donaldson GP, et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell. 2015;161:264–276. doi:10.1016/j.cell.2015.02.047
   PubMed Web of Science ®Google Scholar
• Schwartz J, Murrough JW, Iosifescu DV. Ketamine for treatment-resistant depression: recent developments and clinical applications. Evid Based Ment Health. 2016;19(2):35–38. doi:10.1136/eb-2016-102355
   PubMedGoogle Scholar
• Das R, Emon MPZ, Shahriar M, et al. Higher levels of serum IL-1β and TNF-α are associated with an increased probability of major depressive disorder. Psychiatry Res. 2021;295:113568. doi:10.1016/j.psychres.2020.113568
   PubMed Web of Science ®Google Scholar
• Anjum S, Qusar MMAS, Shahriar M, et al. Altered serum interleukin-7 and interleukin-10 are associated with drug-free major depressive disorder. Ther Adv Psychopharmacol. 2020;10:2045125320916655. doi:10.1177/2045125320916655
   Web of Science ®Google Scholar
• Emon MPZ, Das R, Nishuty NL, et al. Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case-control study with or without antidepressant therapy. BMC Res Notes. 2020;13(1):83. doi:10.1186/s13104-020-04952-3
   PubMed Web of Science ®Google Scholar
• Malik S, Singh R, Arora G, Dangol A, Goyal S. Biomarkers of major depressive disorder: knowing is half the battle. Clin Psychopharmacol Neurosci. 2021;19(1):12–25. doi:10.9758/cpn.2021.19.1.12
   PubMed Web of Science ®Google Scholar
• Bai S, Wang W, Wang T, et al. CD36 deficiency affects depressive-like behaviors possibly by modifying gut microbiota and the inflammasome pathway in mice. Transl Psychiatry. 2021;11(1):16. doi:10.1038/s41398-020-01130-8
   PubMed Web of Science ®Google Scholar
• Fouquier J, Moreno Huizar N, Donnelly J, et al. The gut microbiome in autism: study-site effects and longitudinal analysis of behavior change. mSystems. 2021;6(2):e00848–20. doi:10.1128/mSystems.00848-20
   PubMed Web of Science ®Google Scholar
• Lee J, d’Aigle J, Atadja L, et al. Gut microbiota-derived short-chain fatty acids promote poststroke recovery in aged mice. Circ Res. 2020;127(4):453–465. doi:10.1161/CIRCRESAHA.119.316448
   PubMed Web of Science ®Google Scholar
• Lichota A, Gwozdzinski K, Szewczyk EM. Microbial modulation of coagulation disorders in venous thromboembolism. J Inflamm Res. 2020;13:387–400. doi:10.2147/JIR.S258839
   PubMed Web of Science ®Google Scholar
• Zheng P, Wu J, Zhang H, et al. The gut microbiome modulates gut-brain axis glycerophospholipid metabolism in a region-specific manner in a nonhuman primate model of depression. Mol Psychiatry. 2020. doi:10.1038/s41380-020-0744-2
   Web of Science ®Google Scholar
• Wu M, Tian T, Mao Q, et al. Associations between disordered gut microbiota and changes of neurotransmitters and short-chain fatty acids in depressed mice. Transl Psychiatry. 2020;10(1):350. doi:10.1038/s41398-020-01038-3
   PubMed Web of Science ®Google Scholar
• Chen JJ, Zheng P, Liu YY, et al. Sex differences in gut microbiota in patients with major depressive disorder. Neuropsychiatr Dis Treat. 2018;14:647–655. doi:10.2147/NDT.S159322
   PubMed Web of Science ®Google Scholar
• Chen JJ, He S, Fang L, et al. Age-specific differential changes on gut microbiota composition in patients with major depressive disorder. Aging (Albany NY). 2020;12(3):2764–2776. doi:10.18632/aging.102775
   PubMedGoogle Scholar
• Sanada K, Nakajima S, Kurokawa S, et al. Gut microbiota and major depressive disorder: a systematic review and meta-analysis. J Affect Disord. 2020;266:1–13. doi:10.1016/j.jad.2020.01.102
   PubMed Web of Science ®Google Scholar
• Lai WT, Deng WF, Xu SX, et al. Shotgun metagenomics reveals both taxonomic and tryptophan pathway differences of gut microbiota in major depressive disorder patients. Psychol Med. 2021;51(1):90–101. doi:10.1017/S0033291719003027
   PubMed Web of Science ®Google Scholar
• Pan X, Wen SW, Kaminga AC, Liu A. Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Sci Rep. 2020;10(1):8848. doi:10.1038/s41598-020-65051-8
   PubMed Web of Science ®Google Scholar
• Sae-Khow K, Charoensappakit A, Visitchanakun P, et al. Pathogen-associated molecules from gut translocation enhance severity of cecal ligation and puncture sepsis in iron-overload β-Thalassemia mice. J Inflamm Res. 2020;13:719–735. doi:10.2147/JIR.S273329
   PubMed Web of Science ®Google Scholar
• Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr. 2018;30(1):1–16. doi:10.1017/neu.2016.69
   PubMed Web of Science ®Google Scholar
• Colasanto M, Madigan S, Korczak DJ. Depression and inflammation among children and adolescents: a meta-analysis. J Affect Disord. 2020;277:940–948. doi:10.1016/j.jad.2020.09.025
   PubMed Web of Science ®Google Scholar
• Zheng P, Wang Y, Chen L, et al. Identification and validation of urinary metabolite biomarkers for major depressive disorder. Mol Cell Proteomics. 2013;12(1):207–214. doi:10.1074/mcp.M112.021816
   PubMed Web of Science ®Google Scholar
• Zheng P, Gao HC, Qi ZG, et al. Peripheral metabolic abnormalities of lipids and amino acids implicated in increased risk of suicidal behavior in major depressive disorder. Metabolomics. 2013;9(3):688–696. doi:10.1007/s11306-012-0474-9
   Web of Science ®Google Scholar
• Bai S, Fang L, Xie J, Bai H, Wang W, Chen JJ. Potential biomarkers for diagnosing major depressive disorder patients with suicidal ideation. J Inflamm Res. 2021;14:495–503. doi:10.2147/JIR.S297930
   PubMed Web of Science ®Google Scholar
• Arentsen T, Qian Y, Gkotzis S, et al. The bacterial peptidoglycan-sensing molecule Pglyrp2 modulates brain development and behavior. Mol Psychiatry. 2017;22(2):257–266. doi:10.1038/mp.2016.182
   PubMed Web of Science ®Google Scholar
• Hoyles L, Snelling T, Umlai UK, et al. Microbiome-host systems interactions: protective effects of propionate upon the blood-brain barrier. Microbiome. 2018;6(1):55. doi:10.1186/s40168-018-0439-y
   PubMedGoogle Scholar
• Chen L, Dong B, Gao H, et al. HPV-16 E2/E6 and POU5F1B as biomarkers to determine cervical high-grade squamous lesions and more. J Inflamm Res. 2020;13:813–821. doi:10.2147/JIR.S278911
   PubMed Web of Science ®Google Scholar
• Tang Y, Li Y, Sun J, Pan H, Yao F, Jiao X. Selection of an optimal combination panel to better triage COVID-19 hospitalized patients. J Inflamm Res. 2020;13:773–787. doi:10.2147/JIR.S273193
   PubMed Web of Science ®Google Scholar
• He S, Mao X, Lei H, et al. Peripheral blood inflammatory-immune cells as a predictor of infertility in women with polycystic ovary syndrome. J Inflamm Res. 2020;13:441–450. doi:10.2147/JIR.S260770
   PubMed Web of Science ®Google Scholar
• Liu Y, Duan Y, Li Y. Integrated gene expression profiling analysis reveals probable molecular mechanism and candidate biomarker in Anti-TNFα non-response IBD patients. J Inflamm Res. 2020;13:81–95. doi:10.2147/JIR.S236262
   PubMed Web of Science ®Google Scholar
• Mandrekar JN. Receiver operating characteristic curve in diagnostic test assessment. J Thorac Oncol. 2010;5(9):1315–1316. doi:10.1097/JTO.0b013e3181ec173d
   PubMed Web of Science ®Google Scholar
• Wang S, Tang K, Lu Y, et al. Revealing the role of glycerophospholipid metabolism in asthma through plasma lipidomics. Clin Chim Acta. 2021;513:34–42. doi:10.1016/j.cca.2020.11.026
   PubMed Web of Science ®Google Scholar
• Chávez-Talavera O, Tailleux A, Lefebvre P, Staels B. Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease. Gastroenterology. 2017;152(7):1679–1694.e3. doi:10.1053/j.gastro.2017.01.055
   PubMed Web of Science ®Google Scholar
• Higgins AJ, Lees P. The acute inflammatory process, arachidonic acid metabolism and the mode of action of anti-inflammatory drugs. Equine Vet J. 1984;16(3):163–175. doi:10.1111/j.2042-3306.1984.tb01893.x
   PubMed Web of Science ®Google Scholar
• Liu P, Lu Z, Liu L, et al. NOD-like receptor signaling in inflammation-associated cancers: from functions to targeted therapies. Phytomedicine. 2019;64:152925. doi:10.1016/j.phymed.2019.152925
   PubMed Web of Science ®Google Scholar
• Zhou H, Urso CJ, Jadeja V. Saturated fatty acids in obesity-associated inflammation. J Inflamm Res. 2020;13:1–14. doi:10.2147/JIR.S229691
   PubMed Web of Science ®Google Scholar
• Onomoto K, Onoguchi K, Yoneyama M. Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors. Cell Mol Immunol. 2021;18(3):539–555. doi:10.1038/s41423-020-00602-7
   PubMed Web of Science ®Google Scholar
• Naseribafrouei A, Hestad K, Avershina E, et al. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil. 2014;26(8):1155–1162. doi:10.1111/nmo.12378
   PubMed Web of Science ®Google Scholar
• Jiang H, Ling Z, Zhang Y, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–194. doi:10.1016/j.bbi.2015.03.016
   PubMed Web of Science ®Google Scholar
• Yang CC, Hsiao LD, Yang CM. Galangin inhibits LPS-induced MMP-9 expression via suppressing protein kinase-dependent AP-1 and FoxO1 activation in rat brain astrocytes. J Inflamm Res. 2020;13:945–960. doi:10.2147/JIR.S276925
   PubMed Web of Science ®Google Scholar
• Lisowska B, Jakubiak J, Siewruk K, Sady M, Kosson D. Which idea is better with regard to immune response? Opioid anesthesia or opioid free anesthesia. J Inflamm Res. 2020;13:859–869. doi:10.2147/JIR.S275986
   PubMed Web of Science ®Google Scholar
• Al Rushood M, Al-Eisa A, Al-Attiyah R. Serum and urine interleukin-6 and interleukin-8 levels do not differentiate acute pyelonephritis from lower urinary tract infections in children. J Inflamm Res. 2020;13:789–797. doi:10.2147/JIR.S275570
   PubMed Web of Science ®Google Scholar
• Chang MX, Xiong F. Astaxanthin and its effects in inflammatory responses and inflammation-associated diseases: recent advances and future directions. Molecules. 2020;25(22):5342. doi:10.3390/molecules25225342
   PubMed Web of Science ®Google Scholar
• Felger JC. Role of inflammation in depression and treatment implications. Handb Exp Pharmacol. 2019;250:255–286. doi:10.1159/000343966
   PubMedGoogle Scholar
• Raison CL, Rutherford RE, Woolwine BJ, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry. 2013;70(1):31–41. doi:10.1001/2013.jamapsychiatry.4
   PubMed Web of Science ®Google Scholar
• Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivimäki M. Cumulative meta-analysis of interleukins 6 and 1β, tumour necrosis factor α and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206–215. doi:10.1016/j.bbi.2015.06.001
   PubMed Web of Science ®Google Scholar
• Gui SW, Liu YY, Zhong XG, et al. Plasma disturbance of phospholipid metabolis in major depressive disorder by integration of proteomics and metabolomics. Neuropsychiatr Dis Treat. 2018;14:1451–1461. doi:10.2147/NDT.S164134
   PubMed Web of Science ®Google Scholar